Azithromycin Prices Rose in July 2023 Across the Globe
Azithromycin Prices Rose in July 2023 Across the Globe

Azithromycin Prices Rose in July 2023 Across the Globe

  • 02-Aug-2023 5:09 PM
  • Journalist: Francis Stokes

The prices of Azithromycin API demonstrated an upward trend in July 2023 due to increased demand from end-user healthcare and pharmaceutical industries coupled with limited inventories in the Global market.

Azithromycin is an antibiotic that is used to inhibit the growth of bacteria. It accumulates more effectively in infected tissues compared to other available antibiotics in the market. Azithromycin is widely used in the treatment of respiratory tract infections, inflammatory disorders, cystic fibrosis, genitourinary infections, chronic obstructive pulmonary disease (COPD), and asthma. These factors were responsible to boost the demand of Azithromycin API globally. In addition, increased prevalence of bacterial infections further supported this upward trend.

China’s economic recovery struggling to revive growth momentum. According to the National Bureau of Statistics (NBS), the official manufacturing PMI (Purchasing Managers’ Index) stood at 49.3 in July, from 49.0 in June. However, this number still remained below the 50-mark, suggesting contraction instead of expansion. The factory activity slowed down which resulted in less production activity. Market manufacturers and vendors have limited stock in their warehouses, causing rise in prices of Azithromycin. Moreover, suppliers’ performance worsened causing delayed in shipment delivery time to meet consumers demand in the market which further pushed Azithromycin prices upward. Additionally, the sharp rise in Azithromycin API prices is explained by certain factors such as increased prices of the solvents required to make APIs (Active Pharmaceutical Ingredients). Inflation also slowed down compared to previous month that also supported increased demand from consumer’s side.

China is the major exporter of APIs in many economies including USA and Germany. In United states, there has been expansion is observed in private sector business activity. The consumption activity has increased, with rising rate of new orders. Furthermore, increased input cost and high interest rate further kept the Azithromycin prices on higher side. Apart from that, economic rivalry between China and USA has restricted the export of certain drug APIs like Azithromycin from China that caused the shortage of Azithromycin in US market, which driving the prices up. Similar trend of Azithromycin prices is seen in German market. Interest rate hiked by European Central bank and increased energy prices supported the rise in Azithromycin prices in Germany.

As per the ChemAnalyst analysis, the prices of Azithromycin continued to increase in coming months because of surge in demand from end user industries amid limited inventory level among market providers. Apart from that, there’s an expected improvement in the trading activities that can further contribute to rising the prices of Azithromycin in the global market.

Related News

Baltimore’s Key Bridge Collapse Throws Azithromycin Supply Chain into Disarray
  • 04-Apr-2024 3:55 PM
  • Journalist: Li Hua
Teva Pharmaceuticals Announces Divestment Plans for TAPI Division in Strategic Growth Pivot
  • 14-Feb-2024 5:31 PM
  • Journalist: Bob Duffler
Global Azithromycin Market Showed Diverse Trends in 2023 with a Positive Outlook Ahead
  • 30-Jan-2024 3:05 PM
  • Journalist: Patrick Knight
Bulk Drugs and Drug Intermediates Imports Set to Drop by 12% in FY24
  • 29-Jan-2024 12:31 PM
  • Journalist: Gabreilla Figueroa